Gallbladder Cancer Therapeutics Market: Will "Liquid Biopsies" Catch Biliary Tumors Before Symptoms Appear?
A major trend in the oncology diagnostic sector is the transition to "Non-Invasive Monitoring." The market is identifying "Circulating Tumor DNA (ctDNA) Testing" as a critical value-shifter for the Gallbladder Cancer Therapeutics Market, allowing doctors to detect cancer recurrence months before it shows up on a standard CT scan. This movement is critical because gallbladder cancer is...
0 Yorumlar 0 hisse senetleri 85 Views 0 önizleme